Announced Fri, 10 Jul · 10:58 IST
Board Meeting on 17 Jul 2026 to consider Q1 FY27 unaudited results
Results View source PDF
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+12.2%1-day move
₹1239.30
prior close
₹1253.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+0.2—+2.0+12.2+13.9+11.3+14.6+15.4+36.5————
Up moveDown movePending
AI summary
Tatva Chintan Pharma Chem has informed BSE that its Board will meet on Friday, 17 July 2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30 June 2026 (Q1 FY27). The trading window for designated persons is closed from 1 July 2026 until 48 hours after the results are announced. Scrip Code 543321 on BSE and TATVA on NSE.
Likely market impact
Q1 FY27 earnings are upcoming. Watch for revenue, margins and profit growth versus prior periods once results are declared on 17 July.